Technology Review - Published By MIT
Advertisement

A Nobel for Illuminating Biology

Continued from page 1

By Katherine Bourzac

Wednesday, October 08, 2008

smaller text tool iconmedium text tool iconlarger text tool icon
Colorful creature: This sleeping baby monkey expresses GFP with the gene for the mutant Huntington protein. These animals are being used by researchers to study Huntington’s disease.
Credit: Anthony Chan, Emory University

Martin Chalfie, now chair of the biological sciences department at Columbia University, was the first to demonstrate GFP's value as a genetic tag. Chalfie realized that if the gene for GFP could be connected to the gene for another protein, then it would be possible to watch that gene switch on under the microscope. In 1994, Chalfie demonstrated the technique in a tiny worm called C. elegans, which has fewer than a thousand cells. He attached the GFP gene to part of a C. elegans gene that's only expressed in six of the animal's cells; under a microscope, these six cells glowed green.

Chalfie's work demonstrated that GFP could tell biologists if a cell was expressing a particular gene. Roger Y. Tsien, a professor of biochemistry at the University of California, San Diego, built on the work of both Shimomura and Chalfie by developing many variations on GFP, each of which glows a different color, allowing researchers to track different biological processes within the same cell. By experimenting with variations in the sequence of the GFP gene, Tsien developed proteins that fluoresce in shades of blue and yellow. After Russian researchers developed a complex red fluorescent protein, Tsien also created a simpler-to-use version.

"It is imperative for researchers to map and understand the role of different proteins and their interactions in real time in the body," says Elias Zerhouni, director of the National Institutes of Health, in a statement. "Understanding how this protein machinery malfunctions will increase our knowledge about potential causes of illness and disease and perhaps lead to better treatments."

Comments

  • Is it possible ...
    Is it possible for the research labs to consider re-infecting cancer cells with healthy genetic code? The virus infects to produce disease, so have a virus infect the original code back and make the cell normal and healthy again. If a virus can cause cell metabolism to go one way, auto-immune deficient for example, can't the same virion vehicle be utilized to re-infect and then produce a return to cell normalcy?

    Katherine or Emily or one of the editors at TR should pose this question to someone. I suppose it's worth fifteen, twenty paragraphs of writing for a future article.
    Rate this comment: 12345

    mergatroid
    10/14/2008
    Posts:20
    Avg Rating:
    2/5

Log In

Forgot your password?     Register »
Advertisement

Videos

Laser-Triggered Chemical Reactions
Advertisement
Advertisement
Advertisement
Subscribe to Technology Review's daily e-mail update. Enter your e-mail address

TECHNOLOGY RESOURCES

More Technology News from Forbes

Advertisement
MIT Massachusetts Institute of Technology © 2009 Technology Review. All Rights Reserved.